These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11487337)

  • 21. H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals.
    Ramogida CF; Cawthray JF; Boros E; Ferreira CL; Patrick BO; Adam MJ; Orvig C
    Inorg Chem; 2015 Feb; 54(4):2017-31. PubMed ID: 25621728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system.
    Corneillie TM; Fisher AJ; Meares CF
    J Am Chem Soc; 2003 Dec; 125(49):15039-48. PubMed ID: 14653738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, potentiometric, kinetic, and NMR Studies of 1,4,7,10-tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its complexes with Ca(II), Cu(II), Zn(II) and lanthanide(III) ions.
    Kálmán FK; Baranyai Z; Tóth I; Bányai I; Király R; Brücher E; Aime S; Sun X; Sherry AD; Kovács Z
    Inorg Chem; 2008 May; 47(9):3851-62. PubMed ID: 18380456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental effects on the structure of metal ion-DOTA complexes: an ab initio study of radiopharmaceutical metals.
    Lau EY; Lightstone FC; Colvin ME
    Inorg Chem; 2006 Nov; 45(23):9225-32. PubMed ID: 17083220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.
    Šimeček J; Hermann P; Havlíčková J; Herdtweck E; Kapp TG; Engelbogen N; Kessler H; Wester HJ; Notni J
    Chemistry; 2013 Jun; 19(24):7748-57. PubMed ID: 23613345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, characterization, and X-ray crystal structure of In(DOTA-AA) (AA = p-aminoanilide): a model for 111In-labeled DOTA-biomolecule conjugates.
    Liu S; He Z; Hsieh WY; Fanwick PE
    Inorg Chem; 2003 Dec; 42(26):8831-7. PubMed ID: 14686864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyclen Tri-n-butylphosphonate Ester as Potential Chelator for Targeted Radiotherapy: From Yttrium(III) Complexation to (90)Y Radiolabeling.
    Le Fur M; Beyler M; Lepareur N; Fougère O; Platas-Iglesias C; Rousseaux O; Tripier R
    Inorg Chem; 2016 Aug; 55(16):8003-12. PubMed ID: 27486673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
    Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
    Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auto-assembling of ditopic macrocyclic lanthanide chelates with transition-metal ions. Rigid multimetallic high relaxivity contrast agents for magnetic resonance imaging.
    Paris J; Gameiro C; Humblet V; Mohapatra PK; Jacques V; Desreux JF
    Inorg Chem; 2006 Jun; 45(13):5092-102. PubMed ID: 16780331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
    Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A
    Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DOTAGA-anhydride: a valuable building block for the preparation of DOTA-like chelating agents.
    Bernhard C; Moreau M; Lhenry D; Goze C; Boschetti F; Rousselin Y; Brunotte F; Denat F
    Chemistry; 2012 Jun; 18(25):7834-41. PubMed ID: 22615050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates?
    Šimeček J; Hermann P; Wester HJ; Notni J
    ChemMedChem; 2013 Jan; 8(1):95-103. PubMed ID: 23136062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synthesis and chelation chemistry of DOTA-peptide conjugates.
    De León-Rodríguez LM; Kovacs Z
    Bioconjug Chem; 2008 Feb; 19(2):391-402. PubMed ID: 18072717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
    Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS
    Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.
    DeNardo SJ; DeNardo GL; Yuan A; Richman CM; O'Donnell RT; Lara PN; Kukis DL; Natarajan A; Lamborn KR; Jacobs F; Siantar CL
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3938S-44S. PubMed ID: 14506192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physico-chemical properties of Mn
    Garda Z; Forgács A; Do QN; Kálmán FK; Timári S; Baranyai Z; Tei L; Tóth I; Kovács Z; Tircsó G
    J Inorg Biochem; 2016 Oct; 163():206-213. PubMed ID: 27567150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected aggregation of neutral, xylene-cored dinuclear GdIII chelates in aqueous solution.
    Costa J; Balogh E; Turcry V; Tripier R; Le Baccon M; Chuburu F; Handel H; Helm L; Tóth E; Merbach AE
    Chemistry; 2006 Sep; 12(26):6841-51. PubMed ID: 16770815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of a DOTA--biotin conjugate for radionuclide chelation via Cu-free click chemistry.
    Schultz MK; Parameswarappa SG; Pigge FC
    Org Lett; 2010 May; 12(10):2398-401. PubMed ID: 20423109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of dinuclear heterometallic lanthanide complexes exhibiting MRI and luminescence response.
    Mamedov I; Parac-Vogt TN; Logothetis NK; Angelovski G
    Dalton Trans; 2010 Jun; 39(24):5721-7. PubMed ID: 20485819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
    Chong HS; Ma X; Le T; Kwamena B; Milenic DE; Brady ED; Song HA; Brechbiel MW
    J Med Chem; 2008 Jan; 51(1):118-25. PubMed ID: 18062661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.